ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 574,51
-0,76%
Dow Jones
40 211,72
0,53%
DAX
18 506,64
-0,50%
Brent Oil
83,105
-1,46%
Bitcoin
63 696,66
-1,78%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/11/201715h00Business WireTeva Announces New Organization Structure and Leadership ChangesNYSE:TEVATeva Pharmaceutical Industries Ltd
18/11/201700h31Dow Jones NewsADRs End Higher; JA Solar, NetEase Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201720h19Business WireTeva Announces Prescription Copay Savings Program for Generic Gleevec® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/11/201714h58Dow Jones NewsCardinal Health Names CFO Mike Kaufmann as New CEONYSE:TEVATeva Pharmaceutical Industries Ltd
03/11/201700h22Dow Jones NewsADRs End Mostly Higher; Alibaba, Teva Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
02/11/201718h15Business WireTeva Announces Completion of Plan B One-Step® Divestiture to Foundation Consumer HealthcareNYSE:TEVATeva Pharmaceutical Industries Ltd
02/11/201714h51Dow Jones NewsTeva Cuts Outlook Again in Perfect Storm of ProblemsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/11/201712h00Business WireTeva Reports Third Quarter 2017 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201721h19Business WireTeva Announces Completion of PARAGARD® Divestiture to CooperSurgicalNYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201714h52Business WireTeva Wins Generic Uceris® Patent TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
30/10/201721h01Business WireKåre Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017NYSE:TEVATeva Pharmaceutical Industries Ltd
26/10/201714h00Business WireTeva to Highlight Asthma Data at the 2017 American College of Allergy, Asthma and Immunology Annual Scientific MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/201714h00Business WireTeva to Highlight New Data in Multiple Sclerosis at Joint ECTRIMS – ACTRIMS Congress in ParisNYSE:TEVATeva Pharmaceutical Industries Ltd
17/10/201714h00Business WireTeva Announces Submission of Biologics License Application for Fremanezumab to the U.S. FDANYSE:TEVATeva Pharmaceutical Industries Ltd
16/10/201722h41Dow Jones NewsAllergan Loses Patent Fight in Federal CourtNYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/201719h43Business WireTeva to Report Third Quarter 2017 Financial Results on November 2, 2017NYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201704h50Business WireTEVA PHARMACEUTICAL SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Dead...NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201715h18Business WireTeva Announces tomy’s Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelo...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/201715h26Business WireTeva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL & Launch of Generic Glatiramer Acetate...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/09/201720h38Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
25/09/201720h29Business WireTeva Announces Reintroduction of Generic Depo-Provera® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/09/201704h50PR Newswire (US)TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Dead...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201709h02Dow Jones NewsMakers Of Opioids Are Asked For Data -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201700h35Dow Jones NewsStates Push Ahead With Investigation Into Opioid PainkillersNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201700h15Dow Jones NewsADRs End MixedNYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201716h00Business WireTeva & Nuvelution Pharma Partner to Accelerate Development of AUSTEDO® (deutetrabenazine) Tablets for Use in Tourette Syndro...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201713h30Business WireTeva Completes Amendment to Credit FacilitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201709h02Dow Jones NewsTeva Sells Women's Health Assets -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201717h30Business WireNew Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic ConditionsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201716h58Dow Jones NewsTeva Sells Slate of Women's Health Products in Debt-Reducing MovesNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
LGSTW
Semper Paratus Acquisiti...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés